[
    "{\"step_by_step_thinking\": \"To answer this question, we need to refer to the relevant documents that discuss the WHO 2016 classification of acute leukemia. Document [22] mentions the updated International Consensus Classification (ICC) of B-acute lymphoblastic leukemia (B-ALL) and T-acute lymphoblastic leukemia (T-ALL), which includes revisions to subtypes previously outlined in the 2016 WHO classification and several newly described entities. Document [6] discusses the 2016 revision of the WHO classification of acute myeloid leukemia (AML), which includes changes to several disease categories. Document [17] mentions the category of 'leukemias of ambiguous lineage' in the 2008 edition of the WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. Based on this information, we can determine which of the given options is not a provisional entity as per the WHO 2016 classification of acute leukemia.\", \"answer_choice\": \"C\"}"
]